Abstract
We report a case of primary malignant mixed tumor (MMT) of bone in an 18-year-old boy with X-ray, CT, MR, scintigraphic, FDG PET, and pathologic correlation. Primary MMT of bone is a highly aggressive tumor and presents both a diagnostic and clinical treatment challenge. This tumor is extremely rare and to the best of our knowledge, this is the first report of the diagnostic imaging findings for primary MMT arising from bone in a patient of this age group.
Keywords: Bone tumors, Mixed malignant tumor, Mesenchymal bone tumors, Pleomorphic adenoma
1. Introduction
Myoepithelial tumors consist of a family of morphologically similar lesions with an evolving nomenclature based on anatomic origin: pleomorphic adenoma of salivary gland, chondroid syringoma of skin and myoepithelioma or mixed tumor of somatic soft tissue and bone. Malignant forms, though rare, have been described in most sites and generally carry a poor prognosis [1], [2], [3]. Previous descriptions of this entity have described radiologic findings in adult patients [4], [5]; however, X-ray, CT, MR, and FDG PET imaging findings in a pediatric-age patient have not been previously described. Furthermore, the lesion in this case exhibits a linear dense lace-like matrix on CT which has not been previously described with this lesion.
2. Case report
A previously healthy 18-year-old male developed progressive pain and swelling about the right knee over a 2-month period. He had no family history of malignancy. Five months prior to his diagnosis, he experienced minor trauma while playing and heard his knee “pop” when it hit the trampoline. The ensuing pain and swelling caused him to limp for several days, but the symptoms completely resolved within a week. Otherwise, his past medical history was negative. Three months after his knee injury he developed new pain and swelling of the knee; this progressed rapidly over the next 2 months by which time the knee mass measured approximately 15 cm in diameter. The patient reported a 15-pound weight loss in the months leading up to the diagnosis. He did not have any other systemic symptoms.
Initial radiographs demonstrated an aggressive lesion in the medial condyle of the distal right femur (Figs. 1A and B). CT obtained to characterize matrix showed an aggressive lesion with a focus of dense linear matrix (Fig. 2) with intervening lucent areas. The lesion was felt to be indeterminate at the time, with overall features suspicious for an aggressive lesion such as a high-grade osteosarcoma. Much less likely considerations included secondary malignant degeneration of a cartilaginous lesion such as an enchondroma into chondrosarcoma, given the question of possible cartilaginous component on CT. Whole body Tc-99 MDP bone scan demonstrated abnormal uptake in the right femoral lesion, but no other abnormal areas (Fig. 3). A subsequent MRI demonstrated a large soft tissue mass associated with the osseous lesion and abnormal marrow signal intensity extending to the proximal femoral neck (Figs. 4A–C). Staging PET scan demonstrated metastasis to the lungs and right inguinal and external iliac lymph nodes (Fig. 5).
Fig. 1.
A: Frontal radiograph of the right knee obtained at diagnosis demonstrating an aggressive lesion involving the medial condyle of the right femur with sunburst periosteal reaction (white arrowheads). B: Lateral radiograph obtained at diagnosis demonstrating a large joint effusion (black asterisk), “sunburst” periosteal reaction (white arrowheads), and a dense sclerotic metaphyseal lesion (black arrows). Overall findings were suggestive of an aggressive lesion.
Fig. 2.
Axial image from a contrast enhanced CT of the right knee showing the aggressive lesion in the posterolateral aspect of the right medial femoral condyle. Linear areas of increased density are noted (white arrowheads).
Fig. 3.
Anterior and posterior projections from Tc-99 m whole body bone scan are shown with additional spot images of the right knee. Increased radiotracer uptake is present in the medial right femoral condyle (white arrows), but no other areas of abnormal activity are identified.
Fig. 4.
A: Coronal T2 weighted image of the distal right femur demonstrates a joint effusion (asterisk) with a soft tissue mass surrounding the distal femur predominantly on the medial aspect (white arrowheads). The dense area seen on the radiograph and CT in the medial femoral condyle appears predominantly low in signal (white arrow). Coronal T1 weighted image of the distal right femur demonstrates a joint effusion (asterisk) with a soft tissue mass surrounding the distal femur predominantly on the medial aspect (white arrowheads). B: The dense area seen on the radiograph and CT in the medial femoral condyle appears predominantly low in signal (white arrow). C: Coronal Inversion Recovery MR image of the proximal right femur demonstrating abnormal enhancement extending to the proximal diaphysis of the right femur with extensive abnormal hyperintense signal in the adjacent musculature (white arrows).
Fig. 5.

Coronal Maximum Intensity Projection (MIP) image from FDG-18 whole body PET/CT scan demonstrates increased radiotracer activity in the distal right femur with multiple additional foci of uptake in the proximal humerus, soft tissues of the thigh, pelvis, and lungs.
The incisional biopsy specimen from the right leg consisted of multiple fragments of pink tan soft tissue with focal calcifications. Hematoxylin and eosin stained microscopic sections demonstrated epithelioid cells in cords and solid sheets amid a myxoid to cartilaginous stroma (Fig. 6A and B). Focal areas showed bone arising from endochondral ossification of the cartilage. The tumor cells expressed cytokeratins and S-100. Cytogenetic analysis was remarkable for a clonal t(X;19)(q13;p13.3) translocation. Bone marrow aspirate also showed metastatic disease.
Fig. 6.
Microscopic features of malignant mixed tumor. A: Broad zones of tumor cells are mixed with myxoid and hyaline cartilage (right) stroma (H&E stain, original magnification 100×). B: At high magnification, epithelioid tumor cells form anastomosing cords and show marked nuclear atypia, apoptosis and mitotic activity (H&E stain, original magnification 400×).
This patient was treated with vincristine, adriamycin, and cytoxan, alternating with ifosfamide and etoposide, following the Children's Oncology Group Ewings sarcoma protocol AEWS-0031. The patient initially showed decrease in size of the knee mass, radiographic resolution of most of the pulmonary nodules, and resolution of the bone marrow disease by morphologic assessment of a bone marrow aspirate 2 months later. However, he developed a new right mid-thigh lesion the following month, proven to be malignant mixed tumor by fine needle aspiration. He then developed numerous firm pink keloid-like nodules on the right knee and leg, the largest being 2 cm in height. Subsequent follow up radiographic and PET imaging (Fig. 6) showed progression of disease. He received additional treatment with an aurora kinase inhibitor and subsequently with the combination of irinotecan, temozolomide, and temsirolimus, but he died of progressive disease 7 months from diagnosis.
3. Discussion
Although the nomenclature is evolving, the term “mixed tumor” refers to the presence of both epithelial and mesenchymal, often chondroid, elements [6]. These tumors most commonly occur in the salivary glands, where they are known as “pleomorphic adenomas” and exhibit benign characteristics. Less commonly, mixed tumors occur as primary skin neoplasms and are termed “chondroid synringomas”, and may exhibit more aggressive clinical behavior [3], [6], [7]. The origin of these tumors in somatic soft tissue and bone is controversial, but recent evidence suggests rearrangement of the EWSR1 gene at 22q12 is common in this category [2] The present case demonstrated typical histologic and immunophenotypic characteristics of mixed tumor, and a novel t(X;19)(q13;p13.3) translocation. It remains to be seen whether t(X;19) produces a fusion gene with analogous pathogenetic mechanisms to the more common EWSR1 fusions.
Malignant forms of mixed tumor can occur at any site but primary MMT of bone is extremely rare [4], [5], [1]. Of the reported cases of primary MMT of bone, the average age at presentation ranged between 25 and 44 years [5]. The limited number of reports of this entity in older adult patients occurring in other sites suggests that this lesion may have a period of relatively slow, indolent growth followed by more rapid progression of local invasion and distal metastasis [7]. Treatment recommendations for this lesion are not specific to this tumor, but suggest it be treated as a high-grade sarcoma; there are no reports, however, of a successful treatment regimen.
From an imaging standpoint, this case proved diagnostically challenging. The wide zone of transition between the lesion and normal bone and sunburst pattern periosteal reaction suggested an aggressive lesion. Both radiographs and CT demonstrated confluent dense matrix. The MRI findings of corresponding T1 and T2 hypointensity, suggested osteoid matrix, as cartilaginous matrices are typically T2 hyperintense given increased fluid content. The lesion was initially considered most suspicious for a high-grade osteosarcoma given the aggressive radiographic appearance and metaphyseal location (common for osteosarcoma). However, the overall distribution of metastatic disease, particularly in the bone marrow, was not typical for osteosarcoma.
Close inspection of the tumor matrix on the initial and subsequent 5 month radiographs (Fig. 7), shows an atypical appearance for osteoid matrix that may more closely resemble chondroid matrix. The matrix appears to display a linear dense lace-like pattern (Fig. 8). Of the only two other cases that provide radiographic description of primary osseous mixed tumors, the lesions appear predominantly lytic with chondroid features visible only on histopathologic assessment. This type of linear dense matrix has not been previously described and may represent an imaging variant of this lesion.
Fig. 7.

Coronal Maximum Intensity Projection (MIP) image from FDG-18 whole body PET/CT scan obtained approximately 5 months after presentation demonstrates marked increase in uptake within an enlarging soft tissue mass extending along the proximal right thigh. Activity within several pulmonary lesions is also present. Activity within the left arm related to radiotracer extravasation was also present.
Fig. 8.

Radiograph 5 months after presentation showing more dense lace like matrix within the distal right femoral lesion.
A single case report in an older patient also noted a preceding history of trauma (though this was an open fracture) and suggested the incorporation of skin elements (from which this tumor arises) could have led to the development of that lesion [8]. Given the size of the lesion in this instance, it was more likely that a pathologic fracture was initially sustained which may have contributed to further local invasiveness.
When encountering an aggressive primary bone lesion which does not demonstrate classic appearances, an atypical manifestation of a common disease entity should always be considered first. In cases where the lesion characteristics and disease distribution pattern do not conform to standard, however, less common diagnoses should also be entertained. This case illustrates previously undescribed imaging features and a pattern of disease presentation and progression that may help in the diagnosis and management of future presentations of this rare tumor.
References
- 1.Hornick J.L., Fletcher C.D. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. American Journal of Surgical Pathology. 2003;27(9):1183–1196. doi: 10.1097/00000478-200309000-00001. [DOI] [PubMed] [Google Scholar]
- 2.Antonescu C.R., Zhang L., Chang N.E. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer. 2010;49(12):1114–1124. doi: 10.1002/gcc.20819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Watson J.A., Walker M.M., Smith N.P., Hunt D.M. Malignant chondroid syringoma--a rare cause of secondary bone tumour. Clinical and Experimental Dermatology. 1991;16(4):306–307. doi: 10.1111/j.1365-2230.1991.tb00384.x. [DOI] [PubMed] [Google Scholar]
- 4.Barreto C.A., Lipton M.N., Smith H.B., Potter G.K. Intraosseous chondroid syringoma of the hallux. Journal of the American Academy of Dermatology. 1994;30(2 Pt 2):374–378. doi: 10.1016/s0190-9622(94)70044-3. [DOI] [PubMed] [Google Scholar]
- 5.de Pinieux G., Beabout J.W., Unni K.K., Sim F.H. Primary mixed tumor of bone. Skeletal Radiology. 2001;30(9):534–536. doi: 10.1007/s002560100384. [DOI] [PubMed] [Google Scholar]
- 6.Hirsch P., Helwig E.B. Chondroid syringoma. Mixed tumor of skin, salivary gland type. Archives of Dermatology. 1961;84:835–847. doi: 10.1001/archderm.1961.01580170129018. [DOI] [PubMed] [Google Scholar]
- 7.Barnett M.D., Wallack M.K., Zuretti A., Mesia L., Emery R.S., Berson A.M. Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature. American Journal of Clinical Oncology. 2000;23(3):227–232. doi: 10.1097/00000421-200006000-00003. [DOI] [PubMed] [Google Scholar]
- 8.Gadgil R.K., Ranadive N.U. Chondroid syringoma (mixed tumour) of radius. Indian Journal of Cancer. 1981;18(1):81–83. [PubMed] [Google Scholar]





